Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 8c; Offers FY22 Revenue Guidance
Go back to Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 8c; Offers FY22 Revenue Guidance| Catyalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) | Delayed: 31.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.38 | 52 Week High | $3.00 | |||
| Open | $31.38 | 52 Week Low | $0.51 | |||
| Day High | $31.40 | P/E | N/A | |||
| Day Low | $31.36 | EPS | $-0.25 | |||
| Volume | 2,097,207 | |||||
